---
figid: PMC9257784__etm-24-02-11454-g04
pmcid: PMC9257784
image_filename: etm-24-02-11454-g04.jpg
figure_link: /pmc/articles/PMC9257784/figure/f5-ETM-0-0-11454/
number: Figure 5
figure_title: ''
caption: Mechanistic model of the present study. HIT000218960 enhanced resistance
  to 5-fluorouracil by promoting HMGA2 expression and activating the AKT/mTOR/P70S6K
  pathway in gastric cancer cells. Orange ovals represent phosphorylation modification.
  5-FU, -fluorouracil; HMGA2, high mobility group A2; AKT, protein kinase B; mTOR,
  mammalian receptor of rapamycin; P70S6K, P70S6 kinase.
article_title: lncRNA HIT000218960 enhances resistance to 5-fluorouracil by promoting
  HMGA2 and activating the AKT/mTOR/P70S6K pathway in gastric cancer cells.
citation: Li Bai, et al. Exp Ther Med. 2022 Aug;24(2):527.
year: '2022'

doi: 10.3892/etm.2022.11454
journal_title: Experimental and Therapeutic Medicine
journal_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos

keywords:
- long noncoding RNAs
- HIT000218960
- chemotherapy
- 5-fluorouracil
- gastric cancer
- resistance

---
